Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-02-05FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for sulindac from Actavis Pharma, Inc. This action updates the labeling for the drug under the appro…
-
FDA approval · 2008-01-14FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Celebrex (celecoxib) submitted by Viatris Specialty LLC to update the product labeling under NDA…
-
FDA approval · 2007-11-20FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Meloxicam filed by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2007-11-07FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (generic Naproxen) from Hikma Pharmaceuticals USA Inc., resulting in approval of a gene…
-
FDA approval · 2007-10-25FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved a supplemental application for MELOXICAM from AiPing Pharmaceutical, Inc., resulting in the availability of a generic meloxicam…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-10-17FDA Approved: VOLTAREN ARTHRITIS PAIN — Original Application (Haleon US Holdings LLC)
The FDA approved Voltaren Arthritis Pain (diclofenac sodium) under an original NDA from Haleon US Holdings LLC for relief of osteoarthritis …
-
FDA approval · 2007-10-16FDA Approved: MELOXICAM — Supplemental Application (Terrain Pharmaceuticals, Inc.)
The FDA approved a supplemental application for meloxicam from Terrain Pharmaceuticals, Inc., confirming continued approval for its approved…
-
FDA approval · 2007-09-25FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen from Hikma Pharmaceuticals USA Inc., indicating an approved change or addition to the N…
-
FDA approval · 2007-08-24FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the Diclofenac sodium and misoprostol combination product from Mylan Pharmaceuticals.
-
FDA approval · 2007-07-26FDA Approved: NAPROXEN SODIUM — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approves Dr. Reddy's Laboratories' naproxen sodium as a generic version via an Original Abbreviated New Drug Application (ANDA). This co…
-
FDA approval · 2007-07-15FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
The FDA approved Granules India Ltd's supplemental application for Naproxen (naproxen sodium). This action approves a generic naproxen sodiu…
-
FDA approval · 2007-03-29FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MELOXICAM from Lupin Pharmaceuticals, Inc., indicating regulatory clearance for an updated l…
-
FDA approval · 2007-03-28FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for Meloxicam from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2007-03-28FDA Approved: NAPROXEN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's naproxen generic under an original ANDA, enabling market access for generic naproxen products.
-
FDA approval · 2007-03-16FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for nabumetone by Chartwell RX, LLC, indicating an additional authorization for this generic drug un…
-
FDA approval · 2006-12-20FDA Approved: MELOXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original ANDA for Meloxicam, manufactured by Unichem Pharmaceuticals (USA), Inc., introducing a generic version of the NSAI…
-
FDA approval · 2006-12-19FDA Approved: DG HEALTH NAPROXEN SODIUM — Supplemental Application (Dolgencorp Inc)
FDA approved a supplemental application for DG Health Naproxen Sodium (naproxen sodium) by Dolgencorp Inc. The action approves the generic p…
-
FDA approval · 2006-11-17FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for Etodolac from Taro Pharmaceuticals U.S.A., Inc.
-
FDA approval · 2006-11-17FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for etodolac (generic) submitted by Taro Pharmaceuticals U.S.A., Inc., indicating a supplemental app…
-
FDA approval · 2006-09-22FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, under ANDA074473. This action updates the regulator…
-
FDA approval · 2006-08-08FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC.
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for MELOXICAM, a generic meloxicam product. This marks the first generic approv…
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for MELOXICAM from Zydus Pharmaceuticals USA Inc., granting approval for a generic meloxicam product.
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s generic meloxicam under an original ANDA; the approval covers the standard indications for meloxicam (osteoart…
-
FDA approval · 2006-05-16FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for an ibuprofen product manufactured by Amneal Pharmaceuticals of New York LLC.